^○Shin Sasaki^1,5, Yoriko Nomura^1,5, Sudo Tomoya^1,5, Hisamune Sakai¹, Toru Hisaka¹, Jun Akiba³, Osamu Nakashima⁴, Hirohisa Yano², Masayoshi Kage⁵, Yoshito Akagi¹, Hiroyuki Tanaka¹, Koji Okuda¹ (1.Department of Surgery, Kurume University School of Medicine, Fukuoka, Japan, 2.Department of Pathology, Kurume University School of Medicine, 3.Department of Diagnostic Pathology, Kurume University Hospital, 4.Clinical laboratory, Kurume University Hospital, 5.Division of Molecular Targeting Therapeutics, Research center for Innovative Cancer Therapy, Kurume University School of Medicine)

^○Taiji Tohyama, Kei Tamura, Akihiro Takai, Jota Wtanabe, Hitoshi Inoue, Yoshitomo Ueno, Masahiko Honjo, katunori Sakamoto, Kouhei Ogawa, Yasutugu Takada (Department of Hepato-Biliary-Pancreatic and Breast Surgery, Ehime University, Toon city, Ehime, Japan)

^○Masayasu Aikawa, Yosuke Ueno, Takase Kenichiro, Katsuya Okada, Yukihiro Watanabe, Kojun Okamoto, Hiroshi Sato, Shinich Sakuramoto, Shigeki Yamaguchi, Isamu Koyama (Saitama Medical University, International Medical Center, Saitama, Japan)

^○Tsuyoshi Igami, Yoshitaka Toyoda, Kazuaki Seita, Tomoki Ebata, Yukihiro Yokoyama, Takashi Mizuno, Junpei Yamaguchi, Syunsuke Onoe, Masato Nagino (Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine)

^○Yinzhe Xu, Hongguang Wang, Mingyi Chen, Xianrong Lv, Shichun Lu (Department of Hepatobiliary Surgery, Chinese PLA General Hospital)

^○Tetsuo Ikeda (Center for Integration of Advanced Medicine and Innovative Technology Kyushu University Hospital. 2)